PLCG2 and autoinflammation-PLCG2-associated antibody deficiency-immune dysregulation: We present the first case of APLAID with severely reduced myeloid dendritic cells carrying a novel PLCG2 mutation, and conducted a comprehensive analysis of immunological features in the ALPAID patient, which has not been mentioned in previous reports.